Հոգեմետ դեղերի կիրառումը որպես հանգստացնող միջոցներ (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Հոգեմետ դեղերի կիրառումը որպես հանգստացնող միջոցներ" in Armenian language version.

refsWebsite

Global rank Armenian rank

48nih.gov

4^th place

3^rd place

29doi.org

2^nd place

4^th place

28semanticscholar.org

11^th place

428^th place

21worldcat.org

5^th place

10^th place

10web.archive.org

1^st place

9loc.gov

70^th place

118^th place

4books.google.com

3^rd place

17^th place

4archive.org

6^th place

1fool.com

4,183^rd place

low place

1unodc.org

2,494^th place

1,729^th place

1drugabuse.gov

6,166^th place

7,421^st place

1health.gov.au

low place

4,630^th place

1bmj.com

1,226^th place

503^rd place

1harvard.edu

18^th place

38^th place

1theguardian.com

12^th place

91^st place

1aihw.gov.au

low place

1who.int

195^th place

49^th place

1mayoclinicproceedings.org

low place

3,762^nd place

1gallup.com

2,558^th place

1,246^th place

1infoplease.com

2,027^th place

1,204^th place

1cmaj.ca

low place

3,750^th place

1drugrehab.com

low place

1cultr.com

low place

1queensjournal.ca

low place

1vcu.edu

7,721^st place

low place

aihw.gov.au

«National Drug Strategy Household Survey 2016: detailed findings». Australian Institute of Health and Welfare. The Australian Institute of Health and Welfare. 2017 թ․ սեպտեմբերի 28.

archive.org

Thomas Nordegren (2002). The A-Z Encyclopedia of Alcohol and Drug Abuse. Parkland, Fla.: Brown Walker Press. էջ 327. ISBN 1-58112-404-X.
Thomas Nordegren (2002). The A-Z Encyclopedia of Alcohol and Drug Abuse. Parkland, Fla.: Brown Walker Press. էջ 597. ISBN 1-58112-404-X.
Smith KM, Larive LL, Romanelli F (June 2002). «Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate». American Journal of Health-System Pharmacy. American Society of Health-System Pharmacists. 59 (11): 1067–76. doi:10.1093/ajhp/59.11.1067. eISSN 1535-2900. OCLC 41233599. PMID 12063892. S2CID 44680086.
Wu LT, Schlenger WE, Galvin DM (September 2006). «Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths». Drug and Alcohol Dependence. Elsevier. 84 (1): 102–13. doi:10.1016/j.drugalcdep.2006.01.002. PMC 1609189. PMID 16483730. S2CID 24699584.

bmj.com

bmjopen.bmj.com

Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.

books.google.com

White T (2012). Working with Drug and Alcohol Users. London: Jessica Kingsley Publishers. էջ 77. ISBN 9780857006189.
Fish, Jefferson M (2006). Drugs and Society: U.S. Public Policy (անգլերեն). Rowman & Littlefield. ISBN 9780742542457.
Hunt, Geoffrey; Milhet, Maitena; Bergeron, Henri, eds. (2016). «Part II - Consumption: Cultures of Drug Use». Drugs and Culture: Knowledge, Consumption, and Policy. London and New York: Routledge. էջեր 113–194. ISBN 9781138274426. LCCN 2010048568.
Haenfler, Ross (2015). «Straight Edge». In Parmar, Priya; Nocella II, Anthony J.; Robertson, Scott; Diaz, Martha (eds.). Rebel Music: Resistance through Hip Hop and Punk. Charlotte, North Carolina: Information Age Publishing. էջեր 137–138. ISBN 978-1-62396-910-3.

cmaj.ca

Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.

cultr.com

«Can Hip-Hop Separate Itself From The Drug Culture It Helped Build?». CULTR. 2019 թ․ դեկտեմբերի 18. Արխիվացված օրիգինալից 2020 թ․ դեկտեմբերի 5-ին. Վերցված է 2022 թ․ հունվարի 10-ին.

doi.org

Crocq, Marc-Antoine (December 2007). Thibaut, Florence (ed.). «Historical and cultural aspects of man's relationship with addictive drugs». Dialogues in Clinical Neuroscience. Laboratoires Servier. 9 (4): 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. ISSN 1958-5969. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Lüscher, C; Ungless, MA (November 2006). Bosurgi, R (ed.). «The Mechanistic Classification of Addictive Drugs». PLOS Medicine. Public Library of Science. 3 (11): e437. doi:10.1371/journal.pmed.0030437. ISSN 1549-1676. LCCN 2004212194. PMC 1635740. PMID 17105338. S2CID 12300815.
Earnshaw, VA (December 2020). «Stigma and substance use disorders: A clinical, research, and advocacy agenda». American Psychologist. American Psychological Association. 75 (9): 1300–1311. doi:10.1037/amp0000744. ISSN 1935-990X. PMC 8168446. PMID 33382299. S2CID 229930928.
Saunders, G. R. B.; Wang, X.; Chen, F.; Jang, S. K.; Liu, M.; Wang, C.; Gao, S.; Jiang, Y.; Otto, J. M.; Khunsriraksakul, C.; Akiyama, M. (2022 թ․ դեկտեմբերի 7). «Genetic diversity fuels gene discovery for tobacco and alcohol use». Nature. Nature Research. 612 (7941): 720–724. doi:10.1038/s41586-022-05477-4. ISSN 1476-4687. PMC 9771818. PMID 36477530. S2CID 254434507.
Plant, MA (September 1980). Marsden, J (ed.). «Drugtaking and prevention: the implications of research for social policy». Addiction. Wiley-Blackwell on behalf of the Society for the Study of Addiction. 75 (3): 245–54. doi:10.1111/j.1360-0443.1980.tb01378.x. ISSN 1360-0443. LCCN 93645978. OCLC 27367194. PMID 6938224. S2CID 32438214.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). Horton R (ed.). «Development of a rational scale to assess the harm of drugs of potential misuse». The Lancet. Elsevier. 369 (9566): 1047–53. doi:10.1016/s0140-6736(07)60464-4. ISSN 1474-547X. LCCN sf82002015. OCLC 01755507. PMID 17382831. S2CID 5903121.
Williams, AR (June 2020). «Cannabis as a Gateway Drug for Opioid Use Disorder». Journal of Law, Medicine & Ethics. Cambridge University Press on behalf of the American Society of Law, Medicine & Ethics. 48 (2: Opioid Controversies: The Crisis – Causes and Solutions): 268–274. doi:10.1177/1073110520935338. ISSN 1748-720X. PMC 7359408. PMID 32631185. S2CID 220385267.
Ren, M; Lotfipour, S (September 2019). «Nicotine Gateway Effects on Adolescent Substance Use». Western Journal of Emergency Medicine. eScholarship. 20 (5): 696–709. doi:10.5811/westjem.2019.7.41661. ISSN 1936-9018. PMC 6754186. PMID 31539325. S2CID 201978284.
Balon, R (October 2018). «Illegal or Legal, Marijuana Remains a Gateway Drug». Focus: The Journal of Lifelong Learning in Psychiatry. American Psychiatric Association. 16 (4): 2s–3s. doi:10.1176/appi.focus.164S01. ISSN 1541-4108. PMC 6493246. PMID 31975938. S2CID 169336920.
Barry, AE; King, J; Sears, C; Harville, C; Bondoc, I; Joseph, K (January 2016). «Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink with Illicit Drug Use». Journal of School Health. Wiley-Blackwell on behalf of the American School Health Association. 86 (1): 31–38. doi:10.1111/josh.12351. ISSN 1746-1561. PMID 26645418. S2CID 8906331.
Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.
Parker, EM; Bradshaw, CP (October 2015). «Teen Dating Violence Victimization and Patterns of Substance Use Among High School Students». Journal of Adolescent Health. Elsevier on behalf of the Society for Adolescent Health and Medicine. 57 (4): 441–447. doi:10.1016/j.jadohealth.2015.06.013. ISSN 1054-139X. PMID 26271161. S2CID 40481423.
Chen, CM; Moss, HB; Yi, HY (March 2014). «Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample». Drug and Alcohol Dependence. Elsevier. 136: 51–62. doi:10.1016/j.drugalcdep.2013.12.011. ISSN 0376-8716. PMID 24434016. S2CID 13003820.
Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F (January 2005). «Effects of moderate alcohol consumption on cognitive function in women». The New England Journal of Medicine. Massachusetts Medical Society. 352 (3): 245–253. doi:10.1056/NEJMoa041152. PMID 15659724. S2CID 42052640.
Nutt DJ, King LA, Phillips LD (November 2010). «Drug harms in the UK: a multicriteria decision analysis». Lancet. London, England. 376 (9752): 1558–65. doi:10.1016/S0140-6736(10)61462-6. PMID 21036393. S2CID 5667719.
Moyer VA (May 2014). «Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement». Annals of Internal Medicine. 160 (9): 634–9. doi:10.7326/m14-0334. PMID 24615535.
Martens MP, Page JC, Mowry ES, Damann KM, Taylor KK, Cimini MD (2006). «Differences between actual and perceived student norms: an examination of alcohol use, drug use, and sexual behavior». Journal of American College Health. 54 (5): 295–300. doi:10.3200/JACH.54.5.295-300. PMID 16539222. S2CID 38595391.
Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.
Aikins RD (2015 թ․ հունվարի 2). «From recreational to functional drug use: the evolution of drugs in American higher education, 1960-2014». History of Education. 44 (1): 25–43. doi:10.1080/0046760X.2014.979251. PMC 4972325. PMID 27499559.
Di Forti M (June 2020). Maj M (ed.). «To legalize or not to legalize cannabis, that is the question!». World Psychiatry. Wiley-Blackwell on behalf of the [orld Psychiatric Association. 19 (2): 188–189. doi:10.1002/wps.20737. PMC 7214953. PMID 32394550. S2CID 218598941.
Bahji A, Stephenson C (August 2019). «International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis». International Journal of Environmental Research and Public Health. MDPI. 16 (17): 3095. doi:10.3390/ijerph16173095. PMC 6747067. PMID 31454942. S2CID 201658917.
Pacula RL, Smart R (May 2017). Cannon T, Widiger T (eds.). «Medical Marijuana and Marijuana Legalization». Annual Review of Clinical Psychology. Annual Reviews. 13: 397–419. doi:10.1146/annurev-clinpsy-032816-045128. LCCN 2004212108. PMC 6358421. PMID 28482686. S2CID 3836912.
Smith KM, Larive LL, Romanelli F (June 2002). «Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate». American Journal of Health-System Pharmacy. American Society of Health-System Pharmacists. 59 (11): 1067–76. doi:10.1093/ajhp/59.11.1067. eISSN 1535-2900. OCLC 41233599. PMID 12063892. S2CID 44680086.
Degenhardt L, Copeland J, Dillon P (2005). «Recent trends in the use of "club drugs": an Australian review». Substance Use & Misuse. Taylor & Francis. 40 (9–10): 1241–56. doi:10.1081/JA-200066777. eISSN 1532-2491. LCCN 2006268261. PMID 16048815. S2CID 25509945.
Halpern P, Moskovich J, Avrahami B, Bentur Y, Soffer D, Peleg K (April 2011). «Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions». Human & Experimental Toxicology. SAGE Publications. 30 (4): 259–66. doi:10.1177/0960327110370984. eISSN 1477-0903. LCCN 90031138. PMID 20488845. S2CID 30994214.
Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS (November 2019). «Adverse drug-related effects among electronic dance music party attendees». International Journal of Drug Policy. Elsevier. 73: 81–87. doi:10.1016/j.drugpo.2019.07.005. ISSN 1873-4758. PMC 6899195. PMID 31349134. S2CID 198932918.
Wu LT, Schlenger WE, Galvin DM (September 2006). «Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths». Drug and Alcohol Dependence. Elsevier. 84 (1): 102–13. doi:10.1016/j.drugalcdep.2006.01.002. PMC 1609189. PMID 16483730. S2CID 24699584.
Smiley, Calvin J. (2017). «Addict Rap?: The Shift from Drug Distributor to Drug Consumer in Hip Hop» (PDF). Journal of Hip Hop Studies. Richmond, Virginia: VCU Scholars Compass (Virginia Commonwealth University). 4 (1): 1–24. doi:10.34718/ZBWC-RN03. ISSN 2331-5563. Արխիվացված օրիգինալից 2021 թ․ հուլիսի 6-ին. Վերցված է 2022 թ․ հունվարի 10-ին.

drugabuse.gov

«Drugs, Brains, and Behavior: The Science of Addiction – Drug Misuse and Addiction». www.drugabuse.gov. North Bethesda, Maryland: National Institute on Drug Abuse. 2020 թ․ հուլիսի 13. Վերցված է 2021 թ․ դեկտեմբերի 23-ին.

drugrehab.com

Gonzales, Matt (2020 թ․ մարտի 2) [27 November 2017]. «Rap Culture's Evolution from Glorifying to Decrying Drug Use». Orlando, Florida: DrugRehab.com. Արխիվացված օրիգինալից 2021 թ․ հունվարի 16-ին. Վերցված է 2022 թ․ հունվարի 10-ին.

fool.com

Williams S (2015 թ․ հոկտեմբերի 24). «Specialty Drug Classes That Are Costing Consumers an Arm and a Leg». The Motley Fool.

gallup.com

Robison J (2002 թ․ հուլիսի 2). «Decades of Drug Use: Data From the '60s and '70s». Gallup.com. Վերցված է 2013 թ․ նոյեմբերի 13-ին.

harvard.edu

hsph.harvard.edu

«The Nutrition Source: "Drinks to Consume in Moderation – Alcohol: Balancing Risks and Benefits"». www.hsph.harvard.edu. Boston: Department of Nutrition at the Harvard T.H. Chan School of Public Health. 2021. Արխիվացված օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.

health.gov.au

www1.health.gov.au

«3.1 Reasons why people use drugs». Australian Department of Health. Արխիվացված է օրիգինալից 2021 թ․ նոյեմբերի 6-ին. Վերցված է 2020 թ․ մայիսի 30-ին.

infoplease.com

«Marijuana: History of Marijuana Use». The Columbia Electronic Encyclopedia (6th ed.). Columbia University Press. 2012. OCLC 746941797 – via infoplease.com.

loc.gov

lccn.loc.gov

Lüscher, C; Ungless, MA (November 2006). Bosurgi, R (ed.). «The Mechanistic Classification of Addictive Drugs». PLOS Medicine. Public Library of Science. 3 (11): e437. doi:10.1371/journal.pmed.0030437. ISSN 1549-1676. LCCN 2004212194. PMC 1635740. PMID 17105338. S2CID 12300815.
Plant, MA (September 1980). Marsden, J (ed.). «Drugtaking and prevention: the implications of research for social policy». Addiction. Wiley-Blackwell on behalf of the Society for the Study of Addiction. 75 (3): 245–54. doi:10.1111/j.1360-0443.1980.tb01378.x. ISSN 1360-0443. LCCN 93645978. OCLC 27367194. PMID 6938224. S2CID 32438214.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). Horton R (ed.). «Development of a rational scale to assess the harm of drugs of potential misuse». The Lancet. Elsevier. 369 (9566): 1047–53. doi:10.1016/s0140-6736(07)60464-4. ISSN 1474-547X. LCCN sf82002015. OCLC 01755507. PMID 17382831. S2CID 5903121.
Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.
Pacula RL, Smart R (May 2017). Cannon T, Widiger T (eds.). «Medical Marijuana and Marijuana Legalization». Annual Review of Clinical Psychology. Annual Reviews. 13: 397–419. doi:10.1146/annurev-clinpsy-032816-045128. LCCN 2004212108. PMC 6358421. PMID 28482686. S2CID 3836912.
Hunt, Geoffrey; Milhet, Maitena; Bergeron, Henri, eds. (2016). «Part II - Consumption: Cultures of Drug Use». Drugs and Culture: Knowledge, Consumption, and Policy. London and New York: Routledge. էջեր 113–194. ISBN 9781138274426. LCCN 2010048568.
Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.
Degenhardt L, Copeland J, Dillon P (2005). «Recent trends in the use of "club drugs": an Australian review». Substance Use & Misuse. Taylor & Francis. 40 (9–10): 1241–56. doi:10.1081/JA-200066777. eISSN 1532-2491. LCCN 2006268261. PMID 16048815. S2CID 25509945.
Halpern P, Moskovich J, Avrahami B, Bentur Y, Soffer D, Peleg K (April 2011). «Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions». Human & Experimental Toxicology. SAGE Publications. 30 (4): 259–66. doi:10.1177/0960327110370984. eISSN 1477-0903. LCCN 90031138. PMID 20488845. S2CID 30994214.

mayoclinicproceedings.org

Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Crocq, Marc-Antoine (December 2007). Thibaut, Florence (ed.). «Historical and cultural aspects of man's relationship with addictive drugs». Dialogues in Clinical Neuroscience. Laboratoires Servier. 9 (4): 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. ISSN 1958-5969. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Lüscher, C; Ungless, MA (November 2006). Bosurgi, R (ed.). «The Mechanistic Classification of Addictive Drugs». PLOS Medicine. Public Library of Science. 3 (11): e437. doi:10.1371/journal.pmed.0030437. ISSN 1549-1676. LCCN 2004212194. PMC 1635740. PMID 17105338. S2CID 12300815.
Earnshaw, VA (December 2020). «Stigma and substance use disorders: A clinical, research, and advocacy agenda». American Psychologist. American Psychological Association. 75 (9): 1300–1311. doi:10.1037/amp0000744. ISSN 1935-990X. PMC 8168446. PMID 33382299. S2CID 229930928.
Saunders, G. R. B.; Wang, X.; Chen, F.; Jang, S. K.; Liu, M.; Wang, C.; Gao, S.; Jiang, Y.; Otto, J. M.; Khunsriraksakul, C.; Akiyama, M. (2022 թ․ դեկտեմբերի 7). «Genetic diversity fuels gene discovery for tobacco and alcohol use». Nature. Nature Research. 612 (7941): 720–724. doi:10.1038/s41586-022-05477-4. ISSN 1476-4687. PMC 9771818. PMID 36477530. S2CID 254434507.
Plant, MA (September 1980). Marsden, J (ed.). «Drugtaking and prevention: the implications of research for social policy». Addiction. Wiley-Blackwell on behalf of the Society for the Study of Addiction. 75 (3): 245–54. doi:10.1111/j.1360-0443.1980.tb01378.x. ISSN 1360-0443. LCCN 93645978. OCLC 27367194. PMID 6938224. S2CID 32438214.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). Horton R (ed.). «Development of a rational scale to assess the harm of drugs of potential misuse». The Lancet. Elsevier. 369 (9566): 1047–53. doi:10.1016/s0140-6736(07)60464-4. ISSN 1474-547X. LCCN sf82002015. OCLC 01755507. PMID 17382831. S2CID 5903121.
Williams, AR (June 2020). «Cannabis as a Gateway Drug for Opioid Use Disorder». Journal of Law, Medicine & Ethics. Cambridge University Press on behalf of the American Society of Law, Medicine & Ethics. 48 (2: Opioid Controversies: The Crisis – Causes and Solutions): 268–274. doi:10.1177/1073110520935338. ISSN 1748-720X. PMC 7359408. PMID 32631185. S2CID 220385267.
Ren, M; Lotfipour, S (September 2019). «Nicotine Gateway Effects on Adolescent Substance Use». Western Journal of Emergency Medicine. eScholarship. 20 (5): 696–709. doi:10.5811/westjem.2019.7.41661. ISSN 1936-9018. PMC 6754186. PMID 31539325. S2CID 201978284.
Balon, R (October 2018). «Illegal or Legal, Marijuana Remains a Gateway Drug». Focus: The Journal of Lifelong Learning in Psychiatry. American Psychiatric Association. 16 (4): 2s–3s. doi:10.1176/appi.focus.164S01. ISSN 1541-4108. PMC 6493246. PMID 31975938. S2CID 169336920.
Barry, AE; King, J; Sears, C; Harville, C; Bondoc, I; Joseph, K (January 2016). «Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink with Illicit Drug Use». Journal of School Health. Wiley-Blackwell on behalf of the American School Health Association. 86 (1): 31–38. doi:10.1111/josh.12351. ISSN 1746-1561. PMID 26645418. S2CID 8906331.
Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.
Parker, EM; Bradshaw, CP (October 2015). «Teen Dating Violence Victimization and Patterns of Substance Use Among High School Students». Journal of Adolescent Health. Elsevier on behalf of the Society for Adolescent Health and Medicine. 57 (4): 441–447. doi:10.1016/j.jadohealth.2015.06.013. ISSN 1054-139X. PMID 26271161. S2CID 40481423.
Chen, CM; Moss, HB; Yi, HY (March 2014). «Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample». Drug and Alcohol Dependence. Elsevier. 136: 51–62. doi:10.1016/j.drugalcdep.2013.12.011. ISSN 0376-8716. PMID 24434016. S2CID 13003820.
Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F (January 2005). «Effects of moderate alcohol consumption on cognitive function in women». The New England Journal of Medicine. Massachusetts Medical Society. 352 (3): 245–253. doi:10.1056/NEJMoa041152. PMID 15659724. S2CID 42052640.
Nutt DJ, King LA, Phillips LD (November 2010). «Drug harms in the UK: a multicriteria decision analysis». Lancet. London, England. 376 (9752): 1558–65. doi:10.1016/S0140-6736(10)61462-6. PMID 21036393. S2CID 5667719.
Moyer VA (May 2014). «Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement». Annals of Internal Medicine. 160 (9): 634–9. doi:10.7326/m14-0334. PMID 24615535.
Lord S, Marsch L (December 2011). «Emerging trends and innovations in the identification and management of drug use among adolescents and young adults». Adolescent Medicine. 22 (3): 649–69, xiv. PMC 4119795. PMID 22423469.
Martens MP, Page JC, Mowry ES, Damann KM, Taylor KK, Cimini MD (2006). «Differences between actual and perceived student norms: an examination of alcohol use, drug use, and sexual behavior». Journal of American College Health. 54 (5): 295–300. doi:10.3200/JACH.54.5.295-300. PMID 16539222. S2CID 38595391.
Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.
Aikins RD (2015 թ․ հունվարի 2). «From recreational to functional drug use: the evolution of drugs in American higher education, 1960-2014». History of Education. 44 (1): 25–43. doi:10.1080/0046760X.2014.979251. PMC 4972325. PMID 27499559.
Di Forti M (June 2020). Maj M (ed.). «To legalize or not to legalize cannabis, that is the question!». World Psychiatry. Wiley-Blackwell on behalf of the [orld Psychiatric Association. 19 (2): 188–189. doi:10.1002/wps.20737. PMC 7214953. PMID 32394550. S2CID 218598941.
Bahji A, Stephenson C (August 2019). «International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis». International Journal of Environmental Research and Public Health. MDPI. 16 (17): 3095. doi:10.3390/ijerph16173095. PMC 6747067. PMID 31454942. S2CID 201658917.
Pacula RL, Smart R (May 2017). Cannon T, Widiger T (eds.). «Medical Marijuana and Marijuana Legalization». Annual Review of Clinical Psychology. Annual Reviews. 13: 397–419. doi:10.1146/annurev-clinpsy-032816-045128. LCCN 2004212108. PMC 6358421. PMID 28482686. S2CID 3836912.
Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.
Smith KM, Larive LL, Romanelli F (June 2002). «Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate». American Journal of Health-System Pharmacy. American Society of Health-System Pharmacists. 59 (11): 1067–76. doi:10.1093/ajhp/59.11.1067. eISSN 1535-2900. OCLC 41233599. PMID 12063892. S2CID 44680086.
Degenhardt L, Copeland J, Dillon P (2005). «Recent trends in the use of "club drugs": an Australian review». Substance Use & Misuse. Taylor & Francis. 40 (9–10): 1241–56. doi:10.1081/JA-200066777. eISSN 1532-2491. LCCN 2006268261. PMID 16048815. S2CID 25509945.
Halpern P, Moskovich J, Avrahami B, Bentur Y, Soffer D, Peleg K (April 2011). «Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions». Human & Experimental Toxicology. SAGE Publications. 30 (4): 259–66. doi:10.1177/0960327110370984. eISSN 1477-0903. LCCN 90031138. PMID 20488845. S2CID 30994214.
Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS (November 2019). «Adverse drug-related effects among electronic dance music party attendees». International Journal of Drug Policy. Elsevier. 73: 81–87. doi:10.1016/j.drugpo.2019.07.005. ISSN 1873-4758. PMC 6899195. PMID 31349134. S2CID 198932918.
Wu LT, Schlenger WE, Galvin DM (September 2006). «Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths». Drug and Alcohol Dependence. Elsevier. 84 (1): 102–13. doi:10.1016/j.drugalcdep.2006.01.002. PMC 1609189. PMID 16483730. S2CID 24699584.

ncbi.nlm.nih.gov

Crocq, Marc-Antoine (December 2007). Thibaut, Florence (ed.). «Historical and cultural aspects of man's relationship with addictive drugs». Dialogues in Clinical Neuroscience. Laboratoires Servier. 9 (4): 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. ISSN 1958-5969. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Lüscher, C; Ungless, MA (November 2006). Bosurgi, R (ed.). «The Mechanistic Classification of Addictive Drugs». PLOS Medicine. Public Library of Science. 3 (11): e437. doi:10.1371/journal.pmed.0030437. ISSN 1549-1676. LCCN 2004212194. PMC 1635740. PMID 17105338. S2CID 12300815.
Earnshaw, VA (December 2020). «Stigma and substance use disorders: A clinical, research, and advocacy agenda». American Psychologist. American Psychological Association. 75 (9): 1300–1311. doi:10.1037/amp0000744. ISSN 1935-990X. PMC 8168446. PMID 33382299. S2CID 229930928.
Saunders, G. R. B.; Wang, X.; Chen, F.; Jang, S. K.; Liu, M.; Wang, C.; Gao, S.; Jiang, Y.; Otto, J. M.; Khunsriraksakul, C.; Akiyama, M. (2022 թ․ դեկտեմբերի 7). «Genetic diversity fuels gene discovery for tobacco and alcohol use». Nature. Nature Research. 612 (7941): 720–724. doi:10.1038/s41586-022-05477-4. ISSN 1476-4687. PMC 9771818. PMID 36477530. S2CID 254434507.
Williams, AR (June 2020). «Cannabis as a Gateway Drug for Opioid Use Disorder». Journal of Law, Medicine & Ethics. Cambridge University Press on behalf of the American Society of Law, Medicine & Ethics. 48 (2: Opioid Controversies: The Crisis – Causes and Solutions): 268–274. doi:10.1177/1073110520935338. ISSN 1748-720X. PMC 7359408. PMID 32631185. S2CID 220385267.
Ren, M; Lotfipour, S (September 2019). «Nicotine Gateway Effects on Adolescent Substance Use». Western Journal of Emergency Medicine. eScholarship. 20 (5): 696–709. doi:10.5811/westjem.2019.7.41661. ISSN 1936-9018. PMC 6754186. PMID 31539325. S2CID 201978284.
Balon, R (October 2018). «Illegal or Legal, Marijuana Remains a Gateway Drug». Focus: The Journal of Lifelong Learning in Psychiatry. American Psychiatric Association. 16 (4): 2s–3s. doi:10.1176/appi.focus.164S01. ISSN 1541-4108. PMC 6493246. PMID 31975938. S2CID 169336920.
Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.
Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
Lord S, Marsch L (December 2011). «Emerging trends and innovations in the identification and management of drug use among adolescents and young adults». Adolescent Medicine. 22 (3): 649–69, xiv. PMC 4119795. PMID 22423469.
Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.
Aikins RD (2015 թ․ հունվարի 2). «From recreational to functional drug use: the evolution of drugs in American higher education, 1960-2014». History of Education. 44 (1): 25–43. doi:10.1080/0046760X.2014.979251. PMC 4972325. PMID 27499559.
Di Forti M (June 2020). Maj M (ed.). «To legalize or not to legalize cannabis, that is the question!». World Psychiatry. Wiley-Blackwell on behalf of the [orld Psychiatric Association. 19 (2): 188–189. doi:10.1002/wps.20737. PMC 7214953. PMID 32394550. S2CID 218598941.
Bahji A, Stephenson C (August 2019). «International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis». International Journal of Environmental Research and Public Health. MDPI. 16 (17): 3095. doi:10.3390/ijerph16173095. PMC 6747067. PMID 31454942. S2CID 201658917.
Pacula RL, Smart R (May 2017). Cannon T, Widiger T (eds.). «Medical Marijuana and Marijuana Legalization». Annual Review of Clinical Psychology. Annual Reviews. 13: 397–419. doi:10.1146/annurev-clinpsy-032816-045128. LCCN 2004212108. PMC 6358421. PMID 28482686. S2CID 3836912.
Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.
Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS (November 2019). «Adverse drug-related effects among electronic dance music party attendees». International Journal of Drug Policy. Elsevier. 73: 81–87. doi:10.1016/j.drugpo.2019.07.005. ISSN 1873-4758. PMC 6899195. PMID 31349134. S2CID 198932918.
Wu LT, Schlenger WE, Galvin DM (September 2006). «Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths». Drug and Alcohol Dependence. Elsevier. 84 (1): 102–13. doi:10.1016/j.drugalcdep.2006.01.002. PMC 1609189. PMID 16483730. S2CID 24699584.

queensjournal.ca

Granovsky, Josh (2018 թ․ նոյեմբերի 23). «Emo rap needs to end». The Queen's Journal. Kingston, Ontario: Alma Mater Society of Queen's University. Արխիվացված օրիգինալից 2021 թ․ հուլիսի 24-ին. Վերցված է 2022 թ․ օգոստոսի 7-ին.

semanticscholar.org

api.semanticscholar.org

Crocq, Marc-Antoine (December 2007). Thibaut, Florence (ed.). «Historical and cultural aspects of man's relationship with addictive drugs». Dialogues in Clinical Neuroscience. Laboratoires Servier. 9 (4): 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. ISSN 1958-5969. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Lüscher, C; Ungless, MA (November 2006). Bosurgi, R (ed.). «The Mechanistic Classification of Addictive Drugs». PLOS Medicine. Public Library of Science. 3 (11): e437. doi:10.1371/journal.pmed.0030437. ISSN 1549-1676. LCCN 2004212194. PMC 1635740. PMID 17105338. S2CID 12300815.
Earnshaw, VA (December 2020). «Stigma and substance use disorders: A clinical, research, and advocacy agenda». American Psychologist. American Psychological Association. 75 (9): 1300–1311. doi:10.1037/amp0000744. ISSN 1935-990X. PMC 8168446. PMID 33382299. S2CID 229930928.
Saunders, G. R. B.; Wang, X.; Chen, F.; Jang, S. K.; Liu, M.; Wang, C.; Gao, S.; Jiang, Y.; Otto, J. M.; Khunsriraksakul, C.; Akiyama, M. (2022 թ․ դեկտեմբերի 7). «Genetic diversity fuels gene discovery for tobacco and alcohol use». Nature. Nature Research. 612 (7941): 720–724. doi:10.1038/s41586-022-05477-4. ISSN 1476-4687. PMC 9771818. PMID 36477530. S2CID 254434507.
Plant, MA (September 1980). Marsden, J (ed.). «Drugtaking and prevention: the implications of research for social policy». Addiction. Wiley-Blackwell on behalf of the Society for the Study of Addiction. 75 (3): 245–54. doi:10.1111/j.1360-0443.1980.tb01378.x. ISSN 1360-0443. LCCN 93645978. OCLC 27367194. PMID 6938224. S2CID 32438214.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). Horton R (ed.). «Development of a rational scale to assess the harm of drugs of potential misuse». The Lancet. Elsevier. 369 (9566): 1047–53. doi:10.1016/s0140-6736(07)60464-4. ISSN 1474-547X. LCCN sf82002015. OCLC 01755507. PMID 17382831. S2CID 5903121.
Williams, AR (June 2020). «Cannabis as a Gateway Drug for Opioid Use Disorder». Journal of Law, Medicine & Ethics. Cambridge University Press on behalf of the American Society of Law, Medicine & Ethics. 48 (2: Opioid Controversies: The Crisis – Causes and Solutions): 268–274. doi:10.1177/1073110520935338. ISSN 1748-720X. PMC 7359408. PMID 32631185. S2CID 220385267.
Ren, M; Lotfipour, S (September 2019). «Nicotine Gateway Effects on Adolescent Substance Use». Western Journal of Emergency Medicine. eScholarship. 20 (5): 696–709. doi:10.5811/westjem.2019.7.41661. ISSN 1936-9018. PMC 6754186. PMID 31539325. S2CID 201978284.
Balon, R (October 2018). «Illegal or Legal, Marijuana Remains a Gateway Drug». Focus: The Journal of Lifelong Learning in Psychiatry. American Psychiatric Association. 16 (4): 2s–3s. doi:10.1176/appi.focus.164S01. ISSN 1541-4108. PMC 6493246. PMID 31975938. S2CID 169336920.
Barry, AE; King, J; Sears, C; Harville, C; Bondoc, I; Joseph, K (January 2016). «Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink with Illicit Drug Use». Journal of School Health. Wiley-Blackwell on behalf of the American School Health Association. 86 (1): 31–38. doi:10.1111/josh.12351. ISSN 1746-1561. PMID 26645418. S2CID 8906331.
Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.
Parker, EM; Bradshaw, CP (October 2015). «Teen Dating Violence Victimization and Patterns of Substance Use Among High School Students». Journal of Adolescent Health. Elsevier on behalf of the Society for Adolescent Health and Medicine. 57 (4): 441–447. doi:10.1016/j.jadohealth.2015.06.013. ISSN 1054-139X. PMID 26271161. S2CID 40481423.
Chen, CM; Moss, HB; Yi, HY (March 2014). «Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample». Drug and Alcohol Dependence. Elsevier. 136: 51–62. doi:10.1016/j.drugalcdep.2013.12.011. ISSN 0376-8716. PMID 24434016. S2CID 13003820.
Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F (January 2005). «Effects of moderate alcohol consumption on cognitive function in women». The New England Journal of Medicine. Massachusetts Medical Society. 352 (3): 245–253. doi:10.1056/NEJMoa041152. PMID 15659724. S2CID 42052640.
Nutt DJ, King LA, Phillips LD (November 2010). «Drug harms in the UK: a multicriteria decision analysis». Lancet. London, England. 376 (9752): 1558–65. doi:10.1016/S0140-6736(10)61462-6. PMID 21036393. S2CID 5667719.
Martens MP, Page JC, Mowry ES, Damann KM, Taylor KK, Cimini MD (2006). «Differences between actual and perceived student norms: an examination of alcohol use, drug use, and sexual behavior». Journal of American College Health. 54 (5): 295–300. doi:10.3200/JACH.54.5.295-300. PMID 16539222. S2CID 38595391.
Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.
Di Forti M (June 2020). Maj M (ed.). «To legalize or not to legalize cannabis, that is the question!». World Psychiatry. Wiley-Blackwell on behalf of the [orld Psychiatric Association. 19 (2): 188–189. doi:10.1002/wps.20737. PMC 7214953. PMID 32394550. S2CID 218598941.
Bahji A, Stephenson C (August 2019). «International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis». International Journal of Environmental Research and Public Health. MDPI. 16 (17): 3095. doi:10.3390/ijerph16173095. PMC 6747067. PMID 31454942. S2CID 201658917.
Pacula RL, Smart R (May 2017). Cannon T, Widiger T (eds.). «Medical Marijuana and Marijuana Legalization». Annual Review of Clinical Psychology. Annual Reviews. 13: 397–419. doi:10.1146/annurev-clinpsy-032816-045128. LCCN 2004212108. PMC 6358421. PMID 28482686. S2CID 3836912.
Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.
Smith KM, Larive LL, Romanelli F (June 2002). «Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate». American Journal of Health-System Pharmacy. American Society of Health-System Pharmacists. 59 (11): 1067–76. doi:10.1093/ajhp/59.11.1067. eISSN 1535-2900. OCLC 41233599. PMID 12063892. S2CID 44680086.
Degenhardt L, Copeland J, Dillon P (2005). «Recent trends in the use of "club drugs": an Australian review». Substance Use & Misuse. Taylor & Francis. 40 (9–10): 1241–56. doi:10.1081/JA-200066777. eISSN 1532-2491. LCCN 2006268261. PMID 16048815. S2CID 25509945.
Halpern P, Moskovich J, Avrahami B, Bentur Y, Soffer D, Peleg K (April 2011). «Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions». Human & Experimental Toxicology. SAGE Publications. 30 (4): 259–66. doi:10.1177/0960327110370984. eISSN 1477-0903. LCCN 90031138. PMID 20488845. S2CID 30994214.
Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS (November 2019). «Adverse drug-related effects among electronic dance music party attendees». International Journal of Drug Policy. Elsevier. 73: 81–87. doi:10.1016/j.drugpo.2019.07.005. ISSN 1873-4758. PMC 6899195. PMID 31349134. S2CID 198932918.
Wu LT, Schlenger WE, Galvin DM (September 2006). «Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths». Drug and Alcohol Dependence. Elsevier. 84 (1): 102–13. doi:10.1016/j.drugalcdep.2006.01.002. PMC 1609189. PMID 16483730. S2CID 24699584.

pdfs.semanticscholar.org

Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.

theguardian.com

Nutt D (2011 թ․ մարտի 7). «There is no such thing as a safe level of alcohol consumption». The Guardian.

unodc.org

Global Overview of Drug Demand and Supply (PDF). World Drug Report 2017. United Nations. 2017. էջ 13. ISBN 978-92-1-148291-1. Վերցված է 2018 թ․ հունիսի 9-ին.

vcu.edu

scholarscompass.vcu.edu

Smiley, Calvin J. (2017). «Addict Rap?: The Shift from Drug Distributor to Drug Consumer in Hip Hop» (PDF). Journal of Hip Hop Studies. Richmond, Virginia: VCU Scholars Compass (Virginia Commonwealth University). 4 (1): 1–24. doi:10.34718/ZBWC-RN03. ISSN 2331-5563. Արխիվացված օրիգինալից 2021 թ․ հուլիսի 6-ին. Վերցված է 2022 թ․ հունվարի 10-ին.

web.archive.org

«3.1 Reasons why people use drugs». Australian Department of Health. Արխիվացված է օրիգինալից 2021 թ․ նոյեմբերի 6-ին. Վերցված է 2020 թ․ մայիսի 30-ին.
Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.
Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
«The Nutrition Source: "Drinks to Consume in Moderation – Alcohol: Balancing Risks and Benefits"». www.hsph.harvard.edu. Boston: Department of Nutrition at the Harvard T.H. Chan School of Public Health. 2021. Արխիվացված օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
Bostwick JM (February 2012). «Blurred boundaries: the therapeutics and politics of medical marijuana». Mayo Clinic Proceedings. Elsevier on behalf of the Mayo Clinic. 87 (2): 172–86. doi:10.1016/j.mayocp.2011.10.003. LCCN sc78001722. PMC 3538401. PMID 22305029. S2CID 8654553. Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 14-ին. Վերցված է 2021 թ․ օգոստոսի 20-ին.
Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.
Gonzales, Matt (2020 թ․ մարտի 2) [27 November 2017]. «Rap Culture's Evolution from Glorifying to Decrying Drug Use». Orlando, Florida: DrugRehab.com. Արխիվացված օրիգինալից 2021 թ․ հունվարի 16-ին. Վերցված է 2022 թ․ հունվարի 10-ին.
«Can Hip-Hop Separate Itself From The Drug Culture It Helped Build?». CULTR. 2019 թ․ դեկտեմբերի 18. Արխիվացված օրիգինալից 2020 թ․ դեկտեմբերի 5-ին. Վերցված է 2022 թ․ հունվարի 10-ին.
Granovsky, Josh (2018 թ․ նոյեմբերի 23). «Emo rap needs to end». The Queen's Journal. Kingston, Ontario: Alma Mater Society of Queen's University. Արխիվացված օրիգինալից 2021 թ․ հուլիսի 24-ին. Վերցված է 2022 թ․ օգոստոսի 7-ին.
Smiley, Calvin J. (2017). «Addict Rap?: The Shift from Drug Distributor to Drug Consumer in Hip Hop» (PDF). Journal of Hip Hop Studies. Richmond, Virginia: VCU Scholars Compass (Virginia Commonwealth University). 4 (1): 1–24. doi:10.34718/ZBWC-RN03. ISSN 2331-5563. Արխիվացված օրիգինալից 2021 թ․ հուլիսի 6-ին. Վերցված է 2022 թ․ հունվարի 10-ին.

who.int

apps.who.int

Global status report on alcohol (PDF) (2nd ed.). Geneva: World Health Organization, Dept. of Mental Health and Substance Abuse. 2004. ISBN 9241562722.

worldcat.org

Crocq, Marc-Antoine (December 2007). Thibaut, Florence (ed.). «Historical and cultural aspects of man's relationship with addictive drugs». Dialogues in Clinical Neuroscience. Laboratoires Servier. 9 (4): 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. ISSN 1958-5969. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Lüscher, C; Ungless, MA (November 2006). Bosurgi, R (ed.). «The Mechanistic Classification of Addictive Drugs». PLOS Medicine. Public Library of Science. 3 (11): e437. doi:10.1371/journal.pmed.0030437. ISSN 1549-1676. LCCN 2004212194. PMC 1635740. PMID 17105338. S2CID 12300815.
Earnshaw, VA (December 2020). «Stigma and substance use disorders: A clinical, research, and advocacy agenda». American Psychologist. American Psychological Association. 75 (9): 1300–1311. doi:10.1037/amp0000744. ISSN 1935-990X. PMC 8168446. PMID 33382299. S2CID 229930928.
Saunders, G. R. B.; Wang, X.; Chen, F.; Jang, S. K.; Liu, M.; Wang, C.; Gao, S.; Jiang, Y.; Otto, J. M.; Khunsriraksakul, C.; Akiyama, M. (2022 թ․ դեկտեմբերի 7). «Genetic diversity fuels gene discovery for tobacco and alcohol use». Nature. Nature Research. 612 (7941): 720–724. doi:10.1038/s41586-022-05477-4. ISSN 1476-4687. PMC 9771818. PMID 36477530. S2CID 254434507.
Plant, MA (September 1980). Marsden, J (ed.). «Drugtaking and prevention: the implications of research for social policy». Addiction. Wiley-Blackwell on behalf of the Society for the Study of Addiction. 75 (3): 245–54. doi:10.1111/j.1360-0443.1980.tb01378.x. ISSN 1360-0443. LCCN 93645978. OCLC 27367194. PMID 6938224. S2CID 32438214.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). Horton R (ed.). «Development of a rational scale to assess the harm of drugs of potential misuse». The Lancet. Elsevier. 369 (9566): 1047–53. doi:10.1016/s0140-6736(07)60464-4. ISSN 1474-547X. LCCN sf82002015. OCLC 01755507. PMID 17382831. S2CID 5903121.
Williams, AR (June 2020). «Cannabis as a Gateway Drug for Opioid Use Disorder». Journal of Law, Medicine & Ethics. Cambridge University Press on behalf of the American Society of Law, Medicine & Ethics. 48 (2: Opioid Controversies: The Crisis – Causes and Solutions): 268–274. doi:10.1177/1073110520935338. ISSN 1748-720X. PMC 7359408. PMID 32631185. S2CID 220385267.
Ren, M; Lotfipour, S (September 2019). «Nicotine Gateway Effects on Adolescent Substance Use». Western Journal of Emergency Medicine. eScholarship. 20 (5): 696–709. doi:10.5811/westjem.2019.7.41661. ISSN 1936-9018. PMC 6754186. PMID 31539325. S2CID 201978284.
Balon, R (October 2018). «Illegal or Legal, Marijuana Remains a Gateway Drug». Focus: The Journal of Lifelong Learning in Psychiatry. American Psychiatric Association. 16 (4): 2s–3s. doi:10.1176/appi.focus.164S01. ISSN 1541-4108. PMC 6493246. PMID 31975938. S2CID 169336920.
Barry, AE; King, J; Sears, C; Harville, C; Bondoc, I; Joseph, K (January 2016). «Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink with Illicit Drug Use». Journal of School Health. Wiley-Blackwell on behalf of the American School Health Association. 86 (1): 31–38. doi:10.1111/josh.12351. ISSN 1746-1561. PMID 26645418. S2CID 8906331.
Attia, J; Campbell, E; Dray, J; Bowman, J; Freund, M; Hodder, RK; Lecathelinais, C; Oldmeadow, C; Wiggers, J; Wolfenden, L (August 2017). «Effectiveness of a pragmatic school-based universal resilience intervention in reducing tobacco, alcohol, and illicit substance use in a population of adolescents: Cluster-randomised controlled trial» (PDF). BMJ Open. BMJ Group. 7 (8): e016060. doi:10.1136/bmjopen-2017-016060. ISSN 2044-6055. PMC 5629645. PMID 28821523. S2CID 1475517. Արխիվացված (PDF) օրիգինալից 2019 թ․ ապրիլի 30-ին. Վերցված է 2021 թ․ հոկտեմբերի 1-ին.
Parker, EM; Bradshaw, CP (October 2015). «Teen Dating Violence Victimization and Patterns of Substance Use Among High School Students». Journal of Adolescent Health. Elsevier on behalf of the Society for Adolescent Health and Medicine. 57 (4): 441–447. doi:10.1016/j.jadohealth.2015.06.013. ISSN 1054-139X. PMID 26271161. S2CID 40481423.
Chen, CM; Moss, HB; Yi, HY (March 2014). «Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample». Drug and Alcohol Dependence. Elsevier. 136: 51–62. doi:10.1016/j.drugalcdep.2013.12.011. ISSN 0376-8716. PMID 24434016. S2CID 13003820.
Chiva-Blanch, G; Badimon, L (January 2020). «Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies» (PDF). Nutrients. MDPI. 12 (1: Alcoholic Beverages and Human Health): 108. doi:10.3390/nu12010108. ISSN 2072-6643. PMC 7020057. PMID 31906033. S2CID 210042186. Արխիվացված (PDF) օրիգինալից 2021 թ․ հոկտեմբերի 11-ին. Վերցված է 2021 թ․ հոկտեմբերի 11-ին.
«Marijuana: History of Marijuana Use». The Columbia Electronic Encyclopedia (6th ed.). Columbia University Press. 2012. OCLC 746941797 – via infoplease.com.
Weir E (June 2000). «Raves: a review of the culture, the drugs and the prevention of harm» (PDF). CMAJ. Canadian Medical Association. 162 (13): 1843–8. eISSN 1488-2329. LCCN 87039047. PMC 1231377. PMID 10906922. S2CID 10853457. Արխիվացված (PDF) օրիգինալից 2019 թ․ հունիսի 28-ին. Վերցված է 2021 թ․ օգոստոսի 17-ին.
Smith KM, Larive LL, Romanelli F (June 2002). «Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate». American Journal of Health-System Pharmacy. American Society of Health-System Pharmacists. 59 (11): 1067–76. doi:10.1093/ajhp/59.11.1067. eISSN 1535-2900. OCLC 41233599. PMID 12063892. S2CID 44680086.
Degenhardt L, Copeland J, Dillon P (2005). «Recent trends in the use of "club drugs": an Australian review». Substance Use & Misuse. Taylor & Francis. 40 (9–10): 1241–56. doi:10.1081/JA-200066777. eISSN 1532-2491. LCCN 2006268261. PMID 16048815. S2CID 25509945.
Halpern P, Moskovich J, Avrahami B, Bentur Y, Soffer D, Peleg K (April 2011). «Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions». Human & Experimental Toxicology. SAGE Publications. 30 (4): 259–66. doi:10.1177/0960327110370984. eISSN 1477-0903. LCCN 90031138. PMID 20488845. S2CID 30994214.
Palamar JJ, Acosta P, Le A, Cleland CM, Nelson LS (November 2019). «Adverse drug-related effects among electronic dance music party attendees». International Journal of Drug Policy. Elsevier. 73: 81–87. doi:10.1016/j.drugpo.2019.07.005. ISSN 1873-4758. PMC 6899195. PMID 31349134. S2CID 198932918.
Smiley, Calvin J. (2017). «Addict Rap?: The Shift from Drug Distributor to Drug Consumer in Hip Hop» (PDF). Journal of Hip Hop Studies. Richmond, Virginia: VCU Scholars Compass (Virginia Commonwealth University). 4 (1): 1–24. doi:10.34718/ZBWC-RN03. ISSN 2331-5563. Արխիվացված օրիգինալից 2021 թ․ հուլիսի 6-ին. Վերցված է 2022 թ․ հունվարի 10-ին.